Samuel N. Hazen - 13 Feb 2025 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: CEO, Director
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 13 Feb 2025
Net transactions value: -$1,526,545
Form type: 4
Filing time: 18 Feb 2025, 19:35:37 UTC
Previous filing: 30 Jan 2025
Next filing: 15 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+13,218	+21%	$0.000000	76,418	13 Feb 2025	Direct	F1
transaction	HCA	Common Stock	Tax liability	$1,526,545	-4,742	-6.2%	$321.92	71,676	13 Feb 2025	Direct
holding	HCA	Common Stock						813,320	13 Feb 2025	By LP
holding	HCA	Common Stock						3,012	13 Feb 2025	By 2023 Trust
holding	HCA	Common Stock						14,979	13 Feb 2025	By HD Trust
holding	HCA	Common Stock						16,731	13 Feb 2025	By 2023 GST Trust
holding	HCA	Common Stock						163,918	13 Feb 2025	By 2022 GRAT
holding	HCA	Common Stock						250,000	13 Feb 2025	By 2024 GRAT

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 28, 2022, the reporting person was granted 25,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

Content

On January 28, 2022, the reporting person was granted 25,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.